Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Exicure Inc

XCUR ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$1.25

▼ -4.58%

Market Cap $7.97M · Vol 4.11K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$7.97M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

14.29

Momentum

Beta

3.58

vs Market

52W High

$9.40

86.70% below

52W Low

$1.20

4.17% above

Volume

4.11K

Avg 72.04K

P/B

8.80

Price-to-book

ROE

N/A

Return on equity

Free Float

57.40%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Exicure Inc (XCUR) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does XCUR pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.72%

-27.33%

-60.69%

-69.21%

YTD

-76.94%

-81.75%

-70.76%

-99.30%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-4,946,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-38.35% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	8.80
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	6.37M

Technical Indicators

50-Day SMA	$1.99
200-Day SMA	$3.77
RSI (14)	14.29
Beta	3.58
52-Week High	$9.40
52-Week Low	$1.20

Volume Today	4.11K
Avg Daily Volume (30D)	72.04K
Relative Volume	0.06x
Volatility (10D)	64.07
Volatility (30D)	90.05
Free Float	57.40%

Analyst Consensus

N/A

Current Price $1.25

Mean Target N/A

52W Low$1.20 52W High$9.40

Current

Target

$1.20 $9.40

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00GTJCSC3

ISINUS30205M3097

CountryUnited States of America

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.